Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2966 (LINC02966) is a non-coding RNA gene that does not produce a protein but may have important regulatory roles in the cell. Like other members of the lincRNA family, it can act in chromatin remodeling, transcriptional regulation, and help fine-tune the expression of neighboring genes, showing notable tissue and condition specificity. It is affiliated with high grade glioma in disease-association databases, but its precise molecular mechanism and therapeutic relevance remain to be clarified in primary literature
Not applicable. LINC02966 is not a protein or classic drug target, so no mechanisms of action for drug targeting exist
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2966 (LINC02966).